Ardent Health Partners (NYSE:ARDT – Get Free Report) had its price objective lowered by equities research analysts at Truist Financial from $22.00 to $21.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Truist Financial’s target price indicates a potential upside of 26.20% from the stock’s previous close.
A number of other equities research analysts have also recently weighed in on the stock. JPMorgan Chase & Co. reiterated a “neutral” rating and set a $20.00 price target on shares of Ardent Health Partners in a research report on Tuesday, December 17th. Stephens reiterated an “overweight” rating and issued a $24.00 target price on shares of Ardent Health Partners in a report on Thursday, September 19th. Royal Bank of Canada restated an “outperform” rating and set a $23.00 price target on shares of Ardent Health Partners in a research note on Thursday, November 14th. KeyCorp initiated coverage on Ardent Health Partners in a report on Friday, October 11th. They issued an “overweight” rating and a $24.00 price objective on the stock. Finally, Bank of America cut Ardent Health Partners from a “buy” rating to a “neutral” rating and lowered their target price for the company from $22.00 to $19.00 in a report on Wednesday, November 6th. Two investment analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Buy” and a consensus price target of $22.00.
Get Our Latest Stock Analysis on ARDT
Ardent Health Partners Trading Down 1.2 %
Institutional Investors Weigh In On Ardent Health Partners
A number of institutional investors and hedge funds have recently bought and sold shares of ARDT. Wellington Management Group LLP purchased a new position in Ardent Health Partners during the 3rd quarter worth approximately $28,724,000. Point72 Asset Management L.P. purchased a new position in Ardent Health Partners in the 3rd quarter valued at $27,428,000. Goldentree Asset Management LP purchased a new position in Ardent Health Partners during the 3rd quarter worth $22,897,000. Franklin Resources Inc. purchased a new stake in shares of Ardent Health Partners in the third quarter valued at about $15,839,000. Finally, Allspring Global Investments Holdings LLC acquired a new position in shares of Ardent Health Partners during the third quarter worth about $13,119,000.
Ardent Health Partners Company Profile
Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.
See Also
- Five stocks we like better than Ardent Health Partners
- The 3 Best Retail Stocks to Shop for in August
- From Laggards to Leaders: 3 Stocks Ready to Rebound in 2025
- What Are Treasury Bonds?
- 3 Momentum Picks From 2024 Poised for More Gains in 2025
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- Hidden Gems: 3 Value Stocks to Watch for Strong 2025 Returns
Receive News & Ratings for Ardent Health Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health Partners and related companies with MarketBeat.com's FREE daily email newsletter.